In this episode of the LiverHealthPOD, John, will and Paul

discuss new breakthrough treatments in PBC

For decades, treatment for primary biliary cholangitis (PBC) centred on ursodeoxycholic acid (UDCA or "Urso"). But the therapeutic landscape is rapidly evolving.

In this episode of LiverHealthPOD, we explore the emerging wave of treatments transforming care for PBC.

What do these therapies mean for patients who don’t respond adequately to standard treatment? How do clinicians decide when to escalate therapy? And what might the future hold for disease modification in PBC?

Join us as we unpack the latest science and clinical advances shaping the next chapter in PBC care.

Don't forget to send through any questions (about the liver) to [email protected]